Is a complete NSE/KREBSBIO research report available?

No complete published report is available for nse/KREBSBIO (NSE/KREBSBIO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

NSE/KREBSBIO (NSE/KREBSBIO)

National Stock Exchange of India: NSE/KREBSBIO · INR

₹54.0

+0.69 (+1.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first NSE/KREBSBIO analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.2B
Revenue (ttm)	237.3M
Net income (ttm)	-169.3M
EPS (ttm)	-₹7.85
Volume	5,926
Beta	0.80

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 237.3M
Net income (ttm): -169.3M
EPS (ttm): -₹7.85
Market cap: 1.2B

All NSE/KREBSBIO indicators

Market & fundamental data

Available fields

169

Groups with data

Currency

INR

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	202
Employees Change	11%
Employees Change Percent	5.76
Enterprise value	INR 3.4B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.93
Industry PE Fwd	34.64
Isin	INE268B01013
Last refreshed	2026-07-30
Market cap	INR 1.2B
Price	INR 54.04
Price currency	INR
Rev Per Employee	1,174,831.68x
Sector	Healthcare
Sector PE	46.52
Sector PE Fwd	37.94
Sic	2833
Symbol	nse/KREBSBIO
Website	https://krebsbiochem.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-14.44%
EV/Sales	14.41x
FCF yield	-4.34%
P/B ratio	-0.72x
P/S ratio	4.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-41.49%
EBITDA Margin	-14.43%
Gross margin	98.35%
Gross Profit	INR 233.4M
Gross Profit Growth	-29.87%
Gross Profit Growth Q	534.01%
Gross Profit Growth3 Y	-1.49%
Gross Profit Growth5 Y	84.66%
Net Income	INR -169.3M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-71.35%
Profit Margin	-71.35%
Profit Per Employee	INR -838,272
ROA	-3.7
Roa5y	-7.68
ROCE	-19.62
ROIC	-9.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-29.48%
Cagr3y	-8.13%
Cagr5y	-15.37%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth	-45.21x
Revenue Growth Q	11.62x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-23.07x
Revenue Growth5 Y	-14.74x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 0.14
Assets	INR 1.6B
Cash	INR 1.3M
Current Assets	INR 96.2M
Current Liabilities	INR 1.1B
Debt	INR 2.2B
Debt FCF	INR -44.16
Equity	INR -1.6B
Interest Coverage	-1.39
Liabilities	INR 3.3B
Long Term Assets	INR 1.5B
Long Term Liabilities	INR 2.1B
Net Cash	INR -2.2B
Net Cash By Market Cap	INR -192
Tangible Book Value	INR -1.6B
Tangible Book Value Per Share	INR -75.83
WACC	4.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.09
Inventory Turnover	0.06
Net Working Capital	INR -422.8M
Quick ratio	0
Working Capital	INR -1B
Working Capital Turnover	INR -0.24

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.05%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-29.46%
200-day SMA	61.69
3Y total return	-22.47%
50-day SMA	60.27
50-day SMA vs 200-day SMA	50under200
5Y total return	-56.59%
All Time High	227.9
All Time High Change	-76.29%
All Time High Date	2021-12-31
All Time Low	38.33
All Time Low Change	40.99%
All Time Low Date	2026-03-30
ATR	3.11
Beta	0.8
Ch YTD	-21.73
High	54.64
High52	82.49
High52 Date	2025-09-19
High52ch	-34.49%
Low	53.35
Low52	38.33
Low52 Date	2026-03-30
Low52ch	40.99%
Ma50ch	-10.34%
Price vs 200-day SMA	-12.4%
RSI	42.87
RSI Monthly	42.56
RSI Weekly	41.89
Sharpe ratio	-0.7x
Sortino ratio	-0.93
Total Return	-0.05%
Tr YTD	-21.73
Tr1m	-18.42%
Tr1w	1.05%
Tr3m	-10.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR -98.5M
Operating margin	-41.49

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,066,004%
Net Borrowing	126,298,000
Shares Insiders	26.68%
Shares Institutions	0%
Shares Qo Q	-0.45%
Shares Yo Y	0.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	11,273.6x
Bv Per Share	-75.83
CAPEX	INR -31.7M
Ch1m	-18.42
Ch1w	1.05
Ch1y	-29.46
Ch3m	-10.14
Ch3y	-22.47
Ch5y	-56.59
Ch6m	-7.56
Change	1.29%
Change From Open	1.29
Close	53.35
Days Gap	0
Depreciation Amortization	64,233,000
Dollar Volume	320,241
Earnings Date	2026-08-06
EBIT	INR -98.5M
EBITDA	INR -34.2M
EPS	INR -7.85
F Score	2
FCF	INR -50.9M
FCF EV Yield	-1.49x
Financing CF	55,438,000
Fiscal Year End	March
Founded	1,991
Investing CF	-36,358,000
Is Primary Listing	0
Last Earnings Date	2026-05-21
Last Report Date	2026-03-31
Ma150	59.45
Ma150ch	-9.1%
Ma20	55.12
Ma20ch	-1.96%
Net CF	-125,000
Next Earnings Date	2026-08-06
Open	53.35
Position In Range	53.49
Ppne	1,430,073,000
Price Date	2026-07-29
Relative Volume	0.53x
Revenue	237,316,000x
Tr6m	-7.56%
Volume	5,926

NSE/KREBSBIO (NSE/KREBSBIO)

Coverage state: Market snapshot only — no published research

Generate the first NSE/KREBSBIO analysis

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/KREBSBIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/KREBSBIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NSE/KREBSBIO

Frequently asked questions